Big News from Teal Health: We’ve been awarded a $1.68 million SBIR Grant from the National Cancer Institute (NCI), part of The National Institutes of Health (NIH), to support the development and validation of our at-home cervical cancer screening technology, the Teal Wand?.
The Teal Wand is a purpose-built device that allows a woman to collect her own vaginal sample for human papillomavirus (HPV) testing, a critical piece in cervical cancer prevention - all from the comfort, convenience, and privacy of her home. This grant is will help us bring this life-saving technology to more women, particularly those from underserved and underrepresented communities.
Kara Egan, CEO of Teal Health, shares, "We're honored that the NIH recognizes the importance of our at-home screening technology in increasing access to preventive care and cancer screenings for women in the US. This funding brings us closer to our goal of providing women greater autonomy over their health while advancing the fight to eradicate cervical cancer."
This award also recognizes the incredible work of our research partners and the diverse group of clinical trial participants who have been instrumental in this journey. We are excited about the impact this grant will have on our ability to expand access to critical preventive care and improve outcomes for women nationwide.
Thank you to the National Cancer Institute for your support and belief in our mission to get all women screened for cervical cancer – working towards eradicating this preventable disease.
Stay tuned for more updates as we continue to drive innovation in women’s healthcare!
*The Teal Health Cervical Cancer Screening device is an Investigational Device and is not yet approved by the US FDA.
#WomensHealth #CervicalCancerScreening #Innovation #SBIRGrant #HealthcareAccess #TealHealth #EquityInHealth
Read Full Release Here: https://lnkd.in/gGmst3Um